Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vinorelbine Plus Trastuzumab in 1st-line HER2+ Metastatic Breast Cancer
NCT00433095Phase 2Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in breast cancer, sponsored by Ludwig Maximilian University of Munich. Status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00433095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433095.